Skip to main content

Advertisement

SpringerLink
Log in

Neuromuscular complications after hematopoietic stem cell transplantation

  • Original Article
  • Published:
Supportive Care in Cancer Aims and scope Submit manuscript

Abstract

Purpose

The aim of this study was to analyze the occurrence of neuromuscular symptoms in recipients of allogeneic hematopoietic stem cell transplantation (HSCT) for treatment of malignant hematopoietic disease.

Methods

Among 247 outpatients after allogeneic HSCT, we conducted a prospective non-interventional study between July 2011 and August 2013. During follow-up visits, clinical and electrophysiological findings were correlated to the presence of autoantibodies/alloantibodies and to frequencies of lymphocyte subpopulations in peripheral blood.

Results

Resulting in an incidence of 8.1 %, 20 patients were diagnosed with neuromuscular complications at a median onset of 12 months post-transplant. Five patients (25 %) were identified with polyneuropathy (PNP), ten patients (50 %) with combined PNP and myopathy, four patients (20 %) with myopathy or polymyositis (PM), and one patient (5 %) with myasthenia gravis (MG). Immune-mediated sensorimotor PNP after HSCT is characterized by a predominantly axonal lesion and can be overlapping with neurotoxic side effects. The latency between HSCT and development of PM varied between 60 days and 72 months. In general, PM occurs parallel to graft-versus-host disease (GvHD) after tapering of immunosuppressive medication. Typical clinical features are proximal bilateral limb weakness with muscle atrophy. Autoantibodies (Ab) were detected in 12 patients, myositis-specific Ab only in one patient. In patients with progressive neurological symptoms, a decrease in the CD4/CD8 T cell ratio was observed.

Conclusions

GvHD-related myositis appeared similar to idiopathic myositis regarding clinical and electromyographical findings. As outcome measure, sequential analysis of lymphocyte subpopulations in peripheral blood seems to be more suitable than Ab measurements. Whereas peripheral neuropathies are commonly observed shortly after HSCT, MG is a rare complication in the late post-HSCT phase.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

Abbreviations

AChR Ab:

Acetylcholine receptor antibody

AL:

Acute leukemia

ALL:

Acute lymphocytic leukemia

ANA:

Antinuclear antibodies

AML:

Acute myeloid leukemia

Ab:

Autoantibodies

CK-MB:

Creatine kinase-MB

CLL:

Chronic lymphocytic leukemia

CML:

Chronic myeloid leukemia

GvHD:

Graft-versus-host disease

HSCT:

Hematopoietic stem cell transplantation

ND:

Not done

MCL:

Mantle cell lymphoma

MG:

Myasthenia gravis

MM:

Multiple myeloma

MPN:

Myeloproliferative neoplasm

OMF:

Osteomyelofibrosis

PM:

Polymyositis

PNP:

Polyneuropathy

References

  1. de Brabander C, Cornelissen J, Smitt PA, Vecht CJ, van den Bent MJ (2000) Increased incidence of neurological complications in patients receiving an allogenic bone marrow transplantation from alternative donors. J Neurol Neurosurg Psychiatry 68(1):36–40, Epub 1999/12/22

    Article  PubMed Central  PubMed  Google Scholar 

  2. Teive HA, Funke V, Bitencourt MA, de Oliveira MM, Bonfim C, Zanis-Neto J et al (2008) Neurological complications of hematopoietic stem cell transplantation (HSCT): a retrospective study in a HSCT center in Brazil. Arquivos de neuro-psiquiatria 66(3B):685–690, Epub 2008/10/25

    Article  PubMed  Google Scholar 

  3. Uckan D, Cetin M, Yigitkanli I, Tezcan I, Tuncer M, Karasimav D et al (2005) Life-threatening neurological complications after bone marrow transplantation in children. Bone Marrow Transplant 35(1):71–76, Epub 2004/11/09

    Article  CAS  PubMed  Google Scholar 

  4. Kotani A, Ishikawa T, Matsumura Y, Ichinohe T, Ohno H, Hori T et al (2001) Correlation of peripheral blood OX40 + (CD134+) T cells with chronic graft-versus-host disease in patients who underwent allogeneic hematopoietic stem cell transplantation. Blood 98(10):3162–3164, Epub 2001/11/08

    Article  CAS  PubMed  Google Scholar 

  5. Jaglowski SM, Devine SM (2014) Graft-versus-host disease: why have we not made more progress? Curr Opin Hematol 21(2):141–147, Epub 2014/01/29

    Article  CAS  PubMed  Google Scholar 

  6. Delios AM, Rosenblum M, Jakubowski AA, DeAngelis LM (2012) Central and peripheral nervous system immune mediated demyelinating disease after allogeneic hemopoietic stem cell transplantation for hematologic disease. J Neuro-Oncol 110(2):251–256, Epub 2012/08/24

    Article  CAS  Google Scholar 

  7. Sostak P, Padovan CS, Yousry TA, Ledderose G, Kolb HJ, Straube A (2003) Prospective evaluation of neurological complications after allogeneic bone marrow transplantation. Neurology 60(5):842–848, Epub 2003/03/12

    Article  CAS  PubMed  Google Scholar 

  8. Ahn JS, Cho SH, Kim YK, Yang DH, Bae WK, Shim HJ et al (2009) Polymyositis and myocarditis after donor lymphocyte infusion. Int J Hematol 90(1):113–116, Epub 2009/05/28

    Article  PubMed  Google Scholar 

  9. Allen JA, Greenberg SA, Amato AA (2009) Dermatomyositis-like muscle pathology in patients with chronic graft-versus-host disease. Muscle Nerve 40(4):643–647, Epub 2009/08/12

    Article  PubMed  Google Scholar 

  10. Filipovich AH, Weisdorf D, Pavletic S, Socie G, Wingard JR, Lee SJ et al (2005) National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease: I. Diagnosis and staging working group report. Biol Blood Marrow Transplant J Am Soc Blood Marrow Transplant 11(12):945–956, Epub 2005/12/13

    Article  Google Scholar 

  11. Antonini G, Ceschin V, Morino S, Fiorelli M, Gragnani F, Mengarelli A et al (1998) Early neurologic complications following allogeneic bone marrow transplant for leukemia: a prospective study. Neurology 50(5):1441–1445, Epub 1998/05/22

    Article  CAS  PubMed  Google Scholar 

  12. Couriel DR, Beguelin GZ, Giralt S, De Lima M, Hosing C, Kharfan-Dabaja MA et al (2002) Chronic graft-versus-host disease manifesting as polymyositis: an uncommon presentation. Bone Marrow Transplant 30(8):543–546, Epub 2002/10/16

    Article  CAS  PubMed  Google Scholar 

  13. Dowell JE, Moots PL, Stein RS (1999) Myasthenia gravis after allogeneic bone marrow transplantation for lymphoblastic lymphoma. Bone Marrow Transplant 24(12):1359–1361, Epub 2000/01/11

    Article  CAS  PubMed  Google Scholar 

  14. Openshaw H (1997) Peripheral neuropathy after bone marrow transplantation. Biology of blood and marrow transplantation. J Am Soc Blood Marrow Transplant 3(4):202–209, Epub 1997/11/14

    CAS  Google Scholar 

  15. Lin PC, Hsiao LT, Chen PM (2005) Acute polymyositis after donor lymphocyte infusion. Eur J Haematol 74(2):166–168, Epub 2005/01/19

    Article  PubMed  Google Scholar 

  16. Montoro J, Hernandez-Boluda JC, Arbona C, Solano C (2012) Polymyositis after donor lymphocyte infusion. Int J Hematol 96(3):386–389, Epub 2012/08/21

    Article  PubMed  Google Scholar 

  17. Liu FC, Chen CH, Chao TY (2007) Polymyositis complicating donor lymphocyte infusion after stem cell transplantation for relapsed chronic myeloid leukemia: report of a case and review of literature. Clin Rheumatol 26(7):1207–1210, Epub 2006/08/29

    Article  PubMed  Google Scholar 

  18. Wechalekar A, Cranfield T, Sinclair D, Ganzckowski M (2005) Occurrence of autoantibodies in chronic graft vs. host disease after allogeneic stem cell transplantation. Clin Lab Haematol 27(4):247–249, Epub 2005/07/29

    Article  CAS  PubMed  Google Scholar 

  19. Maillard-Lefebvre H, Morell-Dubois S, Lambert M, Charlanne H, Launay D, Hachulla E et al (2010) Graft-versus-host disease-related polymyositis. Clin Rheumatol 29(4):431–433, Epub 2010/01/14

    Article  PubMed  Google Scholar 

  20. Stevens AM, Sullivan KM, Nelson JL (2003) Polymyositis as a manifestation of chronic graft-versus-host disease. Rheumatology (Oxford) 42(1):34–39, Epub 2003/01/02

    Article  CAS  Google Scholar 

  21. Mackey JR, Desai S, Larratt L, Cwik V, Nabholtz JM (1997) Myasthenia gravis in association with allogeneic bone marrow transplantation: clinical observations, therapeutic implications and review of literature. Bone Marrow Transplant 19(9):939–942, Epub 1997/05/01

    Article  CAS  PubMed  Google Scholar 

  22. Tse S, Saunders EF, Silverman E, Vajsar J, Becker L, Meaney B (1999) Myasthenia gravis and polymyositis as manifestations of chronic graft-versus-host-disease. Bone Marrow Transplant 23(4):397–399, Epub 1999/04/01

    Article  CAS  PubMed  Google Scholar 

  23. Kotani A, Takahashi A, Koga H, Morita R, Fukuyama H, Ichinohe T et al (2002) Myasthenia gravis after allogeneic bone marrow transplantation treated with mycophenolate mofetil monitored by peripheral blood OX40+ CD4+ T cells. Eur J Haematol 69(5–6):318–320, Epub 2002/12/04

    Article  PubMed  Google Scholar 

  24. Nagashima T, Sato F, Chuma T, Mano Y, Sasaki I, Mori M et al (2002) Chronic demyelinating polyneuropathy in graft-versus-host disease following allogeneic bone marrow transplantation. Neuropathol Off J Jpn Soc Neuropathol 22(1):1–8, Epub 2002/05/28

    Google Scholar 

  25. Rabinstein AA, Dispenzieri A, Micallef IN, Inwards DJ, Litzow MR, Wijdicks EF (2003) Acute neuropathies after peripheral blood stem cell and bone marrow transplantation. Muscle Nerve 28(6):733–736, Epub 2003/11/26

    Article  PubMed  Google Scholar 

  26. Lee HJ, Oran B, Saliba RM, Couriel DM, Shin K, Massey P et al (2006) Steroid myopathy in patients with acute graft-versus-host disease treated with high-dose steroid therapy. Bone Marrow Transplant 38(4):299–303, Epub 2006/07/05

    Article  CAS  PubMed  Google Scholar 

Download references

Conflict of interest

The authors declare no conflict of interest. They also state that they have full control of primary data and that they agree to allow the journal to review their data if requested.

Author information

Authors and Affiliations

  1. Department of Neurology, Medical School, University of Duisburg-Essen, Hufelandstraße 55, 45122, Essen, Germany

    Susanne Koeppen & Abhiyrahmi Thirugnanasambanthan

  2. Department of Bone Marrow Transplantation, West German Cancer Center, Medical School, University of Duisburg-Essen, Essen, Germany

    Michael Koldehoff

Authors
  1. Susanne Koeppen
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Abhiyrahmi Thirugnanasambanthan
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Michael Koldehoff
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Susanne Koeppen.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Koeppen, S., Thirugnanasambanthan, A. & Koldehoff, M. Neuromuscular complications after hematopoietic stem cell transplantation. Support Care Cancer 22, 2337–2341 (2014). https://doi.org/10.1007/s00520-014-2225-0

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s00520-014-2225-0

Keywords

Search

Navigation